Aethlon Medical (AEMD) Shares Outstanding (2011 - 2025)

Aethlon Medical (AEMD) has 15 years of Shares Outstanding data on file, last reported at $973213.0 in Q4 2025.

• For the quarter ending Q4 2025, Shares Outstanding rose 456.64% year-over-year to $973213.0; the trailing twelve-month figure through Dec 2025 stood at $973213.0 (up 456.64% YoY), and the FY2025 full-year result was $258531.0, up 686.45% from the prior year.
• Shares Outstanding for Q4 2025 stood at $973213.0, up from $761318.0 in the prior quarter.
• Across five years, Shares Outstanding topped out at $15.4 million in Q4 2021 and bottomed at $32873.0 in Q1 2024.
• The 5-year median for Shares Outstanding is $1.6 million (2022), against an average of $3.8 million.
• The widest annual swing landed in 2024, when Shares Outstanding sank 93.27%; it then jumped 686.45% in 2025.
• A 5-year view of Shares Outstanding shows it stood at $15.4 million in 2021, then tumbled by 85.09% to $2.3 million in 2022, then advanced by 13.04% to $2.6 million in 2023, then tumbled by 93.27% to $174838.0 in 2024, then surged by 456.64% to $973213.0 in 2025.
• The last three Shares Outstanding figures came in at $973213.0 (Q4 2025), $761318.0 (Q3 2025), and $259879.0 (Q2 2025), per Business Quant data.

Peer Comparison